Patent · US Active

Nectin-4 binding miniproteins, conjugates and uses thereof

US12427212B2 · kind B2 · utility

0Cited by

1References

30Claims

0Family size

Assignee

Aktis Oncology, Inc. · US

Inventors

William Blackwell · Raleigh, US
Michael Doligalski · Lutz, US
Paul L. Feldman · Sykesville, US
Isaiah Nathaniel Gober · Durham, US
Brian Goodman · Brookline, US
Hyun Joo Kil · Cary, US
Jeff Kovacs · Raleigh, US
Dasa Lipovsek · Pepperell, US
Trevor Price · Durham, US
Matthew Roden · Princeton, US
James M. Way · Raleigh, US
Ved P. Srivastava · Morrisville, US

Key dates

Filing date	Feb 28, 2025
Grant date	Sep 30, 2025
Priority date	—
Expiry date	Feb 28, 2045

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2318/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are polypeptides and conjugates thereof, including radionuclide conjugates, useful in compositions and methods of treating, diagnosing, monitoring, and/or imaging a disease, disorder, or condition associated with expression of one or more targets, including Nectin-4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.